¼Óº¸
VIP
ÅëÇÕ°Ë»ö

Çѱ¹¾àÁ¦ÇÐȸ, 2021 °úÇÐÀÇ ´Þ ±â³ä ½ÉÆ÷Áö¾ö ¼º·á

¸Ó´ÏÅõµ¥ÀÌ
  • âÁ¶±âȹÆÀ À̵¿¿À ±âÀÚ
  • Ä«Ä«¿ÀÅå °øÀ¯Çϱâ
  • Ä«Ä«¿ÀÅå ³ª¿¡°Ô Àü¼ÛÇϱâ
  • ÆäÀ̽ººÏ
  • Æ®À§ÅÍ
  • ³×À̹ö
  • ÅÚ·¹±×·¥
  • ¹®ÀÚ
  • 2021.04.22 16:18
  • ±ÛÀÚÅ©±âÁ¶Àý

'¹Ì·¡ÁöÇâÀû ½Å¾à °³¹ß ¹æ¹ýÀÇ Åä´ë ±¸Ãà ¹× »õ·Î¿î °³¹ß Àü·« ¼ö¸³'¿¡ °üÇÑ Á¤º¸±³È¯ ¹× Åä·ÐÀÇ Àå ¸¶·Ã

»ç´Ü¹ýÀÎ Çѱ¹¾àÁ¦ÇÐȸ(ȸÀå ±Ç¿À½Â, KIST)´Â Áö³­ 21ÀÏ ¿ÀÀü 9½Ã30ºÎÅÍ ¿ÀÈÄ 5½Ã30ºÐ±îÁö °¢°è ¿¬±¸ÀÚ 150¿© ¸íÀÌ Âü¼®ÇÑ °¡¿îµ¥ 2021 °úÇÐÀÇ ´Þ ±â³ä ½ÉÆ÷Áö¾öÀ» °³ÃÖ, ¼ºÈ²¸®¿¡ ¸¶ÃÆ´Ù°í 22ÀÏ ¹àÇû´Ù.

»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ
»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ
Çѱ¹¾àÁ¦ÇÐȸ¿Í Controlled Release Society Korea Chapter°¡ ÁÖÃÖÇÏ°í Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇùȸ°¡ ÈÄ¿øÇÑ À̹ø ½ÉÆ÷Áö¾öÀº Äڷγª19 »óȲ¿¡ ´ëóÇÏ°í ¹æ¿ª ¼öÄ¢À» ÁؼöÇϱâ À§ÇØ ¿Â¶óÀÎ ÄÁÆÛ·±½º·Î ÁøÇàµÇ¾î ¼­¿ï ´õÄÉÀÌÈ£ÅÚ¿¡¼­ ½Ç½Ã°£À¸·Î Áß°èµÆ´Ù. ½ÉÆ÷Áö¾öÀÇ ÁÖÁ¦´Â 'Advancing convergence technologies to drive novel approaches for health innovation'À¸·Î protein delivery, stem cell/gene editing Ä¡·áÁ¦, RNA vaccine/delivery ºÐ¾ß¿¡¼­ ¶Ù¾î³­ ¾÷Àû°ú È°¹ßÇÑ ¿¬±¸¸¦ ¼öÇàÇÏ´Â ÁßÁø ¹× ½ÅÁø ¿¬±¸ÀÚµéÀÇ ¾àÁ¦ÇÐ °ü·Ã ¿¬±¸ ¼º°ú¸¦ ¼Ò°³ÇÔÀ¸·Î½á ¹Ì·¡ÁöÇâÀûÀÎ ½Å¾à °³¹ß ¹æ¹ýÀÇ Åä´ë¸¦ ±¸ÃàÇÏ°í »õ·Î¿î °³¹ß Àü·«ÀÇ È°·Î¸¦ ¸ð»öÇß´Ù.


»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ
»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ
½ÉÆ÷Áö¾öÀº Çѱ¹¾àÁ¦ÇÐȸ ±Ç¿À½Â ȸÀåÀÇ °³È¸»ç¿Í Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇùȸ ¿øÈñ¸ñ ȸÀåÀÇ Ãà»ç·Î ½ÃÀÛµÆÀ¸¸ç 3°³ÀÇ ¼¼¼ÇÀ¸·Î ³ª´µ¾î ÁøÇàµÆ´Ù. ¿ÀÀü¿¡ ÁøÇàµÈ ù ¹ø° ¼¼¼Ç¿¡¼­´Â ¡âExosome-based delivery of therapeutic proteins (ÃÖöÈñ ´ëÇ¥, ¢ßÀϸ®¾Æ½º¹ÙÀÌ¿À·ÎÁ÷½º) ¡âNext-generation neural interfaces: from fibers to nanomaterials (¹Ú¼ºÁØ ±³¼ö, KAIST ¹ÙÀÌ¿À¹×³ú°øÇаú) ¡âRecent advances in stem cells and gene editing as a treatment for neurological diseases (±èÁ¾ÇÊ ±³¼ö, µ¿±¹´ë È­Çаú)ÀÇ ÁÖÁ¦°¡ ¹ßÇ¥µÆ´Ù.

µÎ ¹ø° ¼¼¼ÇÀÇ ¡âPreclinical and clinical aspects of various SN-38 nanomedicine (¹Ú¿µÈ¯ ´ëÇ¥, ¢ß¿¡½º¿£¹ÙÀÌ¿À»çÀ̾ð½º) ¡âLessons learned from drug interactions studies in drug development (äÀ±Áö ±³¼ö, ¿ì¼®´ë ¾àÇдëÇÐ) ¡âDevelopment of RNA structures for the cancer therapeutic vaccine system (À̱Ը® ±³¼ö, °æ»ó´ë ¾àÇдëÇÐ) ¡âCationic polymer development for mRNA delivery and their application for CRISPR-Cas technology (±èÇöÁø ±³¼ö, ÀÎÇÏ´ë »ý¸í°øÇаú) µîÀÇ ÁÖÁ¦ ¹ßÇ¥¿¡ ÀÌ¾î ¼¼ ¹ø° ¼¼¼ÇÀº ¡âInnovation of microsphere-based drug delivery platform (±èÁÖÈñ ´ëÇ¥, ¢ßÀκ¥Æ¼Áö·¦) ¡âIntroducing Grabody B: ABL Bio's BBB shuttling platform technology and its application (¾È¼º¿ø ¼ö¼®¿¬±¸¿ø, ¿¡À̺ñ¿¤¹ÙÀÌ¿À) ¡âDevelopment of microneedle array patch and its medical applications (ÃÖ¼º¿À ¿¬±¸¼ÒÀå, ¢ßÄõµå¸Þµð½¼)ÀÇ ÁÖÁ¦ ¹ßÇ¥·Î ÁøÇàµÆ´Ù.

Çѱ¹¾àÁ¦ÇÐȸ ±Ç¿À½Â ȸÀåÀº "Äڷγª19 Ææ´õ¹ÍÀÌ Ã˹ßÇÑ ºñ´ë¸é »çȸ¹®È­ÀÇ ¿©ÆÄ·Î DNA(Data, Network, AI) ±â¼úÀÌ ºü¸£°Ô Áøº¸ÇÏ°í ÀÖÀ¸¸ç, ÀÌ¿Í ´õºÒ¾î Á¦¾à, º¸°ÇÀÇ·á ¹× ÇコÄÉ¾î ºÐ¾ß ±â¼úÀÇ ±Û·Î¹ú ȯ°æµµ ±ÞÁøÀûÀ¸·Î º¯ÇÏ°í ÀÖ´Ù. ÀÌ·¯ÇÑ ±Û·Î¹ú ±â¼úÀÇ È¯°æ º¯È­¿¡ ºÎÀÀÇÏ°í ¾àÁ¦ÇÐ ºÐ¾ßÀÇ ÃֽŠÁö½Ä°ú Á¤º¸ Á¦°ø¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö´Â »óȲ¿¡¼­ Çѱ¹¾àÁ¦ÇÐȸ´Â ½Å¾à°³¹ß Á¤º¸±³È¯ ¹× Àü·« ¼ö¸³¿¡ µµ¿òÀÌ µÇ°íÀÚ 2021 °úÇÐÀÇ ´Þ ±â³ä ½ÉÆ÷Áö¾öÀ» °³ÃÖÇß´Ù"¸ç ƯÈ÷ "À̹ø ½ÉÆ÷Áö¾öÀÌ Ç×ü ¹× ¹é½Å µîÀÇ ´Ü¹éÁúÄ¡·áÁ¦ °³¹ß ¹× Çõ½Å°³·® ¹ÙÀÌ¿ÀÀǾàÇ°ÀÇ Á¦Á¶, »ý»ê, Ç°Áú, ÀÎÇã°¡ ÀÚ·á °³¹ß¿¡ µµ¿òÀÌ µÇ±â¸¦ ¹Ù¶ó¸ç, º» ½ÉÆ÷Áö¾ö¿¡ °ü·Ã ½Ç¹«ÀÚ ¹× ¿¬±¸Àڵ鲲¼­ ¸¹ÀÌ Âü¼®ÇÏ¿© ÇмúÀû ±³·ù¿Í ³×Æ®¿öÅ·ÀÇ ÀåÀÌ µÇ¾ú±â¸¦ Èñ¸ÁÇÑ´Ù"°í ¸»Çß´Ù.




¸Ó´ÏÅõµ¥ÀÌ ÁÖ¿ä´º½º

"³ªÀÌÅ°¡¤¾Æµð´Ù½º ¸»°í¡¦" ÆÝ·¯´×Á· ´ÃÀÚ ¸ÅÃâ ´ë¹Ú ³­ ºê·£µå
³×À̹ö ¸ÞÀο¡¼­ ¸Ó´ÏÅõµ¥ÀÌ ±¸µ¶ Ä«Ä«¿ÀÅå¿¡¼­ ¸Ó´ÏÅõµ¥ÀÌ Ã¤³Î Ãß°¡

º£½ºÆ®Å¬¸¯

¿À´ÃÀÇ ²ÜÆÁ

  • ´º½º ¼Ó ¿À´Ã
  • ´õ¿µ»ó
  • ³¯¾¾´Â?
  • ÇコÅõµ¥ÀÌ

¸¹ÀÌ º» ´º½º

ºÎµ¿»ê À¯Æ©ºê Á¤º¸Ã¤³Î ºÎ¸´Áö
Ç®¹ÎÁö

Æ÷Åä / ¿µ»ó